{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:30:40Z","timestamp":1789831840780,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":5224,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.3945\/jn.108.090704","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T18:00:45Z","timestamp":1228759245000},"page":"2070-2075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects"],"prefix":"10.1016","volume":"138","author":[{"given":"Kirsten B.","family":"Holven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Retterst\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Otterdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Bjerkeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiv","family":"Ose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit S.","family":"Nenseter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/jn.108.090704_bib1","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.3945\/jn.108.090704_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.3945\/jn.108.090704_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0895-4356(02)00434-1","article-title":"Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies","volume":"55","author":"Bautista","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.3945\/jn.108.090704_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.3945\/jn.108.090704_bib5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3945\/jn.108.090704_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3945\/jn.108.090704_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.CIR.90.2.769","article-title":"Associations of the Hdl(2)-cholesterol and Hdl(3)-cholesterol subfractions with the development of ischemic-heart-disease in british men: the Caerphilly and Speedwell Collaborative Heart-Disease Studies","volume":"90","author":"Sweetnam","year":"1994","journal-title":"Circulation"},{"key":"10.3945\/jn.108.090704_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0021-9150(02)00361-1","article-title":"High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study","volume":"166","author":"Yu","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.3945\/jn.108.090704_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115483","article-title":"High-density cholesterol as a predictor of cardiovascular disease mortality in men and women:the follow-up study of the lipid research clinics prevalence study","volume":"131","author":"Jacobs","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.3945\/jn.108.090704_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J Clin Invest"},{"key":"10.3945\/jn.108.090704_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00125-006-0574-z","article-title":"The impact of glycation on apo A-1 structure and its ability to activate lecithin:cholesterol acyltransferase","volume":"50","author":"Nobecourt","year":"2007","journal-title":"DIABETOLOGIA"},{"key":"10.3945\/jn.108.090704_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/meta.2003.50033","article-title":"Effect of homocysteinylation on human high-density lipoproteins: a correction with paraoxonase activity","volume":"52","author":"Ferretti","year":"2003","journal-title":"Metabolism"},{"key":"10.3945\/jn.108.090704_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpendmet0245","article-title":"Mechanisms of disease: proatherogenic HDL-an evolving field","volume":"2","author":"Navab","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.3945\/jn.108.090704_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.ATV.0000013288.35930.90","article-title":"Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects","volume":"22","author":"Holven","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/jn.108.090704_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1538-7836.2006.02275.x","article-title":"Enhanced platelet activation in hyperhomocysteinemic individuals","volume":"5","author":"Holven","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.3945\/jn.108.090704_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00335510500429821","article-title":"Increased levels of high-sensitivity C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects","volume":"66","author":"Holven","year":"2006","journal-title":"Scand J Clin Lab Invest"},{"key":"10.3945\/jn.108.090704_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jn\/136.4.877","article-title":"Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release and to promote cholesterol efflux","volume":"136","author":"Ottestad","year":"2006","journal-title":"J Nutr"},{"key":"10.3945\/jn.108.090704_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cccn.2005.03.050","article-title":"Altered composition of HDL(3) in FH subjects causing a HDL subfraction with less atheroprotective function","volume":"359","author":"Balstad","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.3945\/jn.108.090704_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.3945\/jn.108.090704_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0003319707311722","article-title":"Effect of statins on serum apolipoprotein j and paraoxonase-1 levels in patients with ischemic heart disease undergoing coronary angiography","volume":"59","author":"Poulakou","year":"2008","journal-title":"Angiology"},{"key":"10.3945\/jn.108.090704_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.mca.0000135221.32523.a1","article-title":"The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia","volume":"15","author":"Kural","year":"2004","journal-title":"Coron Artery Dis"},{"key":"10.3945\/jn.108.090704_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1185\/030079904125004394","article-title":"Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia","volume":"20","author":"Paragh","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.3945\/jn.108.090704_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","article-title":"Elevated homocysteine reduces apolipoprotein A-1 expression in hyperhomocysteinemic mice and in males with coronary artery disease","volume":"98","author":"Mikael","year":"2006","journal-title":"Circ Res"},{"key":"10.3945\/jn.108.090704_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-1 protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ Res"},{"key":"10.3945\/jn.108.090704_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","article-title":"The paradox of dysfunctional high-density lipoprotein","volume":"18","author":"Ansell","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.3945\/jn.108.090704_bib26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.metabol.2006.06.001","article-title":"Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus","volume":"55","author":"Lakshman","year":"2006","journal-title":"Metabolism"},{"key":"10.3945\/jn.108.090704_bib27","first-page":"885","article-title":"Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans","volume":"50","author":"Lacinski","year":"2004","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.3945\/jn.108.090704_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinbiochem.2006.05.010","article-title":"Hyperhomocysteinemia, paraoxonase activity and risk of coronary disease","volume":"39","author":"Kerkeni","year":"2006","journal-title":"Clin Biochem"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622097139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622097139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/138\/11\/2070\/23901401\/2070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T07:12:24Z","timestamp":1687677144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316622097139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0022316622097139"],"URL":"https:\/\/doi.org\/10.3945\/jn.108.090704","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/jn.108.090704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}